Omega Healthcare Investors (NYSE:OHI – Get Free Report) was upgraded by investment analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating in a report issued on Monday, Marketbeat Ratings reports. The brokerage presently has a $45.00 price target on the real estate investment trust’s stock. BMO Capital Markets’ price objective would indicate a potential upside of 14.65% from the stock’s previous close.
Other analysts have also issued reports about the stock. Berenberg Bank began coverage on shares of Omega Healthcare Investors in a research report on Friday, October 18th. They issued a “buy” rating and a $45.00 price objective on the stock. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective on the stock in a research report on Thursday, October 31st. Truist Financial increased their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Mizuho increased their price objective on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the stock a “neutral” rating in a research report on Thursday, December 5th. Finally, Wells Fargo & Company reaffirmed an “overweight” rating and set a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Omega Healthcare Investors presently has a consensus rating of “Moderate Buy” and an average price target of $40.18.
View Our Latest Stock Report on Omega Healthcare Investors
Omega Healthcare Investors Stock Up 0.0 %
Insider Buying and Selling at Omega Healthcare Investors
In other news, COO Daniel J. Booth sold 56,725 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 36.19 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. The trade was a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by insiders.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in OHI. UMB Bank n.a. lifted its position in Omega Healthcare Investors by 353.4% during the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock valued at $27,000 after purchasing an additional 516 shares during the period. True Wealth Design LLC acquired a new position in Omega Healthcare Investors during the third quarter valued at $31,000. Dunhill Financial LLC acquired a new position in Omega Healthcare Investors during the third quarter valued at $31,000. DiNuzzo Private Wealth Inc. acquired a new position in Omega Healthcare Investors during the third quarter valued at $33,000. Finally, V Square Quantitative Management LLC lifted its position in Omega Healthcare Investors by 49.5% during the third quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock valued at $40,000 after purchasing an additional 323 shares during the period. Hedge funds and other institutional investors own 65.25% of the company’s stock.
Omega Healthcare Investors Company Profile
Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.
Further Reading
- Five stocks we like better than Omega Healthcare Investors
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- Market Cap Calculator: How to Calculate Market Cap
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- How to invest in marijuana stocks in 7 steps
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.